Your Article Summary
See Latest ArticlesFuture perspectives in the treatment of atopic dermatitis
Journal of Dermatology, 07/02/09
Katoh N - In this review, the limitations of the currently available therapies and the advantages and disadvantages of new approaches for the treatment of atopic dermatitis including topical and systemic immunosuppressants as well as biologics and anti-pruritic agents are discussed. Potential new cellular targets for the treatment of atopic dermatitis are also illustrated.
Related Articles
Severe radiation dermatitis in patients with locally advanced head and neck cancer treated with concurrent radiation and cetuximab
American Journal of Clinical Oncology, 10/09/09
Relevance Score: 88%
Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Pediatric Drugs, 11/06/09
Relevance Score: 85%
Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis
Pediatric Allergy and Immunology, 10/15/09
Relevance Score: 85%
Association of the toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis
Allergy, 10/13/09
Relevance Score: 85%
Structured education program improves the coping with atopic dermatitis in children and their parents--a multicenter, randomized controlled trial
Journal of Psychosomatic Research, 10/09/09
Relevance Score: 85%
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
A new two-phase dimeticone pediculicide shows high efficacy in a comparative bioassay
BMC Dermatology, 12/15/09
Tinea capitis: still an unsolved problem
Mycoses, 12/15/09
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
Journal of the National Cancer Institute, 12/15/09